"EO 14398"; IDIQ: chemistry, manufacturing and controls and related services for development of drug products (trnd 3)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95026D00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products Solicitation · 75N95025R00005 · Posted Nov 30, 2024
- Last date to order 6% complete
- IDV ceiling
- $49,885,703.00
- Maximum order
- $49,885,703.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded an Indefinite Delivery Contract to Sri International for chemistry, manufacturing, and controls services in support of drug product development, with a contract ceiling of $49,885,703 and an award date of July 3, 2026. This is a multiple-award IDIQ with no set-aside restriction.
Work is performed at the primary location in Potomac, Maryland. The IDIQ supports comprehensive CMC services across small molecules, peptides, biologics, gene therapy vectors, and nanoparticles, including formulation development, current Good Manufacturing Practice (cGMP) manufacturing, analytical method development, stability testing, and quality control activities. Typical production quantities range from 500–5,000 units for non-GMP products and 1,000–10,000 units for cGMP clinical trial materials.
The period of performance runs from September 30, 2025, through July 31, 2031 (six-year ordering period). The contract carries a minimum guaranteed value of $1,000. Technical evaluation of the underlying solicitation prioritized Technical Plan/Approach (40 points), Scientific and Technical Personnel (20 points), Facilities and Equipment (15 points), Quality Management (15 points), and Organizational Experience (10 points). The solicitation included subcontracting goals of 32% small business, 5% small disadvantaged business, 5% women-owned small business, 3% HUBZone, and 3% veteran-owned small business.
Quick answers
Who was awarded contract 75N95026D00001?
75N95026D00001 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on July 3, 2026.
How much is contract 75N95026D00001 worth?
75N95026D00001's own ceiling is $49,885,703. A single order can be worth up to $49,885,703.
Who can order from contract 75N95026D00001?
75N95026D00001 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95026D00001 competed?
The extent of competition for 75N95026D00001 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV